
Abbott Labs (ABT) Stock Forecast & Price Target
Abbott Labs (ABT) Analyst Ratings
Bulls say
Abbott Laboratories is predicted to have a strong future outlook due to its strong medical device portfolio, growth strategies, and international expansion in high-growth areas. The company has shown a commitment to sustainability and has a positive impact on their stock price, expecting continued growth in the second half of the year with approval for new devices and clinical trials. Despite some challenges in the Chinese market and currency headwinds, ABT has a strong pipeline of new products and has beaten expectations in Q2, leading to a positive outlook for the company's future.
Bears say
Abbott Laboratories is a diversified healthcare company with a focus on cardiovascular and diabetes devices, nutritional products, and diagnostic equipment. While the company's international exposure provides potential for growth, its reliance on the diabetes care segment and potential competition in key markets present risks to its long-term outlook. Additionally, with a projected slowdown in diabetes sales, adjusted estimates and a potential resurgence of COVID-19, the company may face challenges in achieving its financial targets.
This aggregate rating is based on analysts' research of Abbott Labs and is not a guaranteed prediction by Public.com or investment advice.
Abbott Labs (ABT) Analyst Forecast & Price Prediction
Start investing in Abbott Labs (ABT)
Order type
Buy in
Order amount
Est. shares
0 shares